St Jude Financial Ratios

St Jude Medical Inc -- USA Stock  

USD 80.82  0.01  0.0124%

Use fundamental data analysis to confirm all available fundamental indicators of St Jude Medical to find out if markets are now mispricing the corporation. We found twenty-nine available financial indicators for St Jude which can be compared to its peers in the sector. To make sure the equity is not overpriced, please validate all St Jude Medical Inc fundamentals including its Shares Owned by Insiders, Cash per Share, Working Capital, as well as the relationship between Price to Sales and Earnings Per Share . Given that St Jude Medical has Number of Shares Shorted of 8.18 M, we advise you double-check St Jude latest market performance to make sure the company can sustain itself next year.Use St Jude to enhance returns of your portfolios. The stock experiences normal upward fluctuation. Check odds of St Jude to be traded at $84.86 in 30 days

St Jude Medical Valuation Over Time

Enterprise Value

St Jude Company Summary

St Jude competes with Edwards Lifesciences, Digirad, and DarioHealth Corp. St. Jude Medical, Inc., together with its subsidiaries, develops, manufactures, and distributes cardiovascular medical devices for cardiac rhythm management, cardiovascular, and atrial fibrillation therapy areas worldwide.

St Jude Price to Sales vs Working Capital

St Jude Medical Inc is rated second in price to sales category among related companies. It is currently regarded as top stock in working capital category among related companies reporting about  160,000,000  of Working Capital per Price to Sales.

St Jude Market Fundamentals

 Change(%) 0.0124%
< 50% 

Chance of Financial Distress

St Jude Medical Inc has    50 (%) percent chance of experiencing financial distress in the next 2 years of operations. More Info


St Jude Growth Changes

EPS Diluted Growth

EPS Growth

NCFO Growth


Compare St Jude To Peers
Michael Rousseau CEO and President COO and Director
Sarah Bates Non-Executive Chairman of the Board
More Executives

Opportunity Range

February 21, 2018 Opportunity Range